COMPARATIVE IN-VITRO ACTIVITIES OF NEW QUINOLONES AGAINST CORYNEFORM BACTERIA

被引:15
作者
MARTINEZMARTINEZ, L [1 ]
SUAREZ, AI [1 ]
ORTEGA, MC [1 ]
PEREA, EJ [1 ]
机构
[1] UNIV SEVILLA,HOSP VIRGEN MACARENA,DEPT MICROBIOL,E-41080 SEVILLE,SPAIN
关键词
D O I
10.1128/AAC.38.6.1439
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of eight quinolones against 115 coryneform bacteria (20 Corynebacterium jeikeium, 15 Corynebacterium minutissimum, 15 Corynebacterium striatum, 25 Corynebacterium urealyticum, 10 Corynebacterium xerosis, 10 Corynebacterium group ANF-1, 10 Corynebacterium group 12, and 10 Listeria monocytogenes) were determined. The MICs of ciprofloxacin, ofloxacin, and sparfloxacin for 90% of C. jeikeuim, C. urealyticum, and C. xerosis isolates tested were >16 mu g/ml. Those of BAY Y 3118 and clinafloxacin against these species were 0.5 and 1 to 2 mu g/ml, respectively. The MICs for 90% of all 115 strains tested were 0.5 mu g/ml for BAY Y 3118, 1 mu g/ml for clinafloxacin, 2 mu g/ml for E-5068, 4 mu g/ml for E-5065, and >16 mu g/ml for ciprofloxacin, ofloxacin, sparfloxacin, and E-4868.
引用
收藏
页码:1439 / 1441
页数:3
相关论文
共 12 条
[1]   CORYNEFORM BACTERIA IN INFECTIOUS-DISEASES - CLINICAL AND LABORATORY ASPECTS [J].
COYLE, MB ;
LIPSKY, BA .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (03) :227-246
[2]   INVITRO ACTIVITY OF 79 ANTIMICROBIAL AGENTS AGAINST CORYNEBACTERIUM GROUP-D2 [J].
GARCIARODRIGUEZ, JA ;
SANCHEZ, JEG ;
BELLIDO, JLM ;
MAYORAL, TN ;
SANCHEZ, EG ;
GARCIA, IG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2140-2143
[3]   LISTERIOSIS [J].
GELLIN, BG ;
BROOME, CV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (09) :1313-1320
[4]  
Hollis DG, 1981, GRAM POSITIVE ORGANI
[5]   THE INVITRO ACTIVITY OF PD127,391, A NEW QUINOLONE [J].
KING, A ;
BOOTHMAN, C ;
PHILLIPS, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (02) :135-141
[6]   INVITRO ACTIVITY OF CIPROFLOXACIN AGAINST GROUP-JK CORYNEBACTERIA [J].
MACHKA, K ;
BALG, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (04) :375-375
[7]   COMPARATIVE INVITRO ACTIVITY OF PD-127391, A NEW FLUORINATED 4-QUINOLONE DERIVATIVE [J].
NORRBY, SR ;
JONSSON, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1278-1281
[8]   INVITRO SUSCEPTIBILITY OF CORYNEBACTERIUM GROUP-D2 AND CORYNEBACTERIUM-JEIKEIUM TO 12 ANTIBIOTICS [J].
PHILIPPON, A ;
BIMET, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (12) :892-895
[9]   SUSCEPTIBILITY OF URINARY ISOLATES OF CORYNEBACTERIUM GROUP-D2 TO 15 ANTIMICROBIALS AND ACETOHYDROXAMIC ACID [J].
SORIANO, F ;
PONTE, C ;
SANTAMARIA, M ;
TORRES, A ;
FERNANDEZROBLAS, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (03) :349-355
[10]   INVITRO ACTIVITY OF PD-127391, AN ENHANCED-SPECTRUM QUINOLONE [J].
WISE, R ;
ASHBY, JP ;
ANDREWS, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1251-1256